BAY 94-9027 Provides Safe and Effective Long-Term Prophylaxis in Pediatric Patients: Results from the PROTECT VIII Kids Extension Study

被引：2
|
作者：
Ahuja, Sanjay
Fischer, Kathelijn
Biss, Tina
Enriquez, Monika Maas
Mancuso, Maria-Elisa
Steele, MacGregor
Wang, Maria
Kenet, Gili
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-140303
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] BAY 94-9027 provides effective long-term prophylaxis in pediatric patients: Interim results of the PROTECT VIII Kids extension study
    Kenet, Gili
    Biss, Tina
    Steele, MacGregor
    Linardi, Camila
    Tseneklidou-Stoeter, Despina
    Saxena, Kapil
    [J]. HAEMOPHILIA, 2018, 24 : 15 - 15
  • [2] EFFECTIVE PROPHYLAXIS WITH BAY 94-9027 IN ADOLESCENTS WITH HEMOPHILIA A: RESULTS FROM THE PROTECT VIII MAIN STUDY AND ONGOING EXTENSION
    Kerlin, Bryce
    Ducore, Jonathan
    Ahuja, Sanjay
    Afonja, Olubunmi
    Saxena, Kapil
    [J]. PEDIATRIC BLOOD & CANCER, 2018, 65
  • [3] BAY 94-9027 PROVIDED EFFECTIVE LONG-TERM PROPHYLAXIS IN PEDIATRIC PATIENTS AGED ≥ 12 YEARS AT THE END OF THE PROTECT VIII KIDS EXTENSION STUDY, INDICATING CONSISTENT SAFETY OF TREATMENT INTO ADOLESCENCE
    Ahuja, S.
    Fischer, K.
    Biss, T.
    Enriquez, M. Maas
    Mancuso, M. E.
    Steele, M.
    Wang, M.
    Kenet, G.
    [J]. HAEMOPHILIA, 2021, 27 : 48 - 48
  • [4] Safety of long-term prophylaxis with BAY 94-9027: Interim results of >5 years of treatment in the PROTECT VIII extension trial
    Reding, Mark T.
    Ng, Hen Joo
    Tseneklidou-Stoefer, Despina
    Linardi, Camila
    Lalezari, Shadan
    [J]. HAEMOPHILIA, 2018, 24 : 17 - 18
  • [5] CONFIRMED SAFETY PROFILE OF BAY 94-9027 PROPHYLAXIS FOR ≥5 YEARS: OUTCOMES FROM THE PROTECT VIII AND PROTECT VIII KIDS EXTENSION STUDIES
    Mancuso, M. E.
    Holme, P. A.
    Kenet, G.
    Simpson, M.
    Di Minno, M. N. D.
    Baumann, A.
    Enriquez, Maas M.
    Reding, M. T.
    [J]. HAEMATOLOGICA, 2021, 106 (09) : 7 - 8
  • [6] Effective protection for >5 years with bay 94-9027 prophylaxis: interim results from the protect VIII extension trial
    Thomson, G.
    Holme, P. A.
    Wang, M.
    Enriquez, M. Maas
    [J]. HAEMOPHILIA, 2018, 24 : 114 - 114
  • [7] PROTECT VIII kids extension study: Long-term safety and efficacy of BAY 94-9027 (damoctocog alfa pegol) in children with severe haemophilia A
    Mancuso, Maria Elisa
    Biss, Tina
    Fischer, Kathelijn
    Enriquez, Monika Maas
    Steele, MacGregor
    Wang, Maria
    Tseneklidou-Stoeter, Despina
    Ahuja, Sanjay
    Kenet, Gili
    [J]. HAEMOPHILIA, 2021, 27 (03) : 434 - 444
  • [8] EFFICACY AND SAFETY OF BAY 94-9027 IS SUSTAINED FOR 5 YEARS: OUTCOMES IN PATIENTS FROM THE PROTECT VIII AND PROTECT VIII KIDS EXTENSION STUDIES
    Santagostino, E.
    Di Minno, M. N. D.
    Lalezari, S.
    Kenet, G.
    Enriquez, M. Maas
    Wang, M.
    Reding, M.
    [J]. HAEMOPHILIA, 2020, 26 : 73 - 73
  • [9] Confirmed long-term safety and efficacy of prophylactic treatment with BAY 94-9027 in severe haemophilia A: final results of the PROTECT VIII extension study
    Reding, Mark T.
    Pabinger, Ingrid
    Holme, Pal Andre
    Poulsen, Lone
    Negrier, Claude
    Chalasani, Pavani
    Enriquez, Monika Maas
    Wang, Maria
    Meijer, Karina
    Mancuso, Maria Elisa
    Lalezari, Shadan
    [J]. HAEMOPHILIA, 2021, 27 (03) : E347 - E356
  • [10] COMPARISON OF BLEEDING RATES BEFORE AND DURING BAY 94-9027 PROPHYLAXIS: DATA FROM THE PROTECT VIII STUDY AND EXTENSION
    Kerlin, Bryce A.
    Simpson, Mindy L.
    Reding, Mark T.
    Linardi, Camila
    Schwartz, Lawrence
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (09) : E32 - E32
12345